Adele Costabile

Adele Costabile is a Professor in Clinical Nutrition and the Microbiome at the University of Roehampton, UK. She holds a PhD in Food Science from the University of Naples, Italy, and has extensive experience spanning academic research, teaching, and industry collaboration. Formerly a Lecturer in Nutrition (2015–2017), she now leads the Clinical Nutrition and Microbiome research group within the School of Life and Health Sciences. Her work focuses on gut microbiota, diet-microbiome interactions, and translational research in nutritional interventions.

Education:

• PhD in Food Science, University of Naples Federico II, Italy (2004)
• BSc/MSc in Food Science, University of Naples Federico II, Italy (2000)
• International Qualification in Endocrinology, Nephrology, and Nutritional Sciences (2023)

Research Interests: Host-microbe interactions, gut microbiota modulation via diet, functional foods, and translational research bridging academia and industry. Her studies explore how dietary changes influence gut microbiota to combat metabolic and neurological disorders.

Publications & Impact: Over 60 peer-reviewed articles and chapters, recognized by Web of Science as a highly cited researcher (top 1%). Recent work includes studies on fermented beetroot’s effects on prediabetes and the role of diet in PCOS management. Articles often bridge microbiology, nutrition, and clinical outcomes.

Awards & Grants:

• British Council/Newton Award (2015)
• Coeliac UK MSc Dissertation Sponsor (2018)
• Lead PI on a €858K UKRI-MRC Grant (2023) for ‘PreVegDiet’

Supervision & Teaching: Supervised 12+ PhD students and postdocs, leading modules in Clinical Nutrition, Food Science, and Public Health. She chairs the School of Life and Health Sciences and contributes to curriculum development.

Labs & Collaborations: Founded the University of Roehampton’s gut microbiome lab, housing in vitro fermentation systems. Collaborates with institutions like Imperial College London, Vilnius University, and companies like Optibiotix and Vemico.